Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (?-ketoglutarate) and CO2.
This report elaborates on the current development of the Isocitrate Dehydrogenase Inhibitors industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Tragara/Adastra
Daiichi Sankyo
Beigene
Tesaro
Celgene
Bayer
Bristol-Myers Squibb
Tocagen
Aslan Pharmaceuticals
By Type:
Others
IDH2 Mutant Medullary Malignant Tumor
IDH1 Mutant Medullary Malignant Tumor
By Application:
Hedgehog Pathway Inhibitor
Others
FLT3 Inhibitor
DH Inhibitor
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Isocitrate Dehydrogenase Inhibitors Market Overview 2018-2029
-
1.1 China Isocitrate Dehydrogenase Inhibitors Industry Development Overview
-
1.2 China Isocitrate Dehydrogenase Inhibitors Industry Development History
-
1.3 China Isocitrate Dehydrogenase Inhibitors Industry Market Size (2018-2029)
-
1.4 China Isocitrate Dehydrogenase Inhibitors Market Analysis by Type from Production Side
-
1.4.1 China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of IDH2 Mutant Medullary Malignant Tumor (2018-2029)
-
1.4.3 China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of IDH1 Mutant Medullary Malignant Tumor (2018-2029)
-
1.5 China Isocitrate Dehydrogenase Inhibitors Market Analysis by Application from Consumption End
-
1.5.1 China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of Hedgehog Pathway Inhibitor (2018-2029)
-
1.5.2 China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of FLT3 Inhibitor (2018-2029)
-
1.5.4 China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of DH Inhibitor (2018-2029)
-
1.6 China Isocitrate Dehydrogenase Inhibitors Market Analysis by Region
-
1.6.1 North China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
Chapter 2 China Isocitrate Dehydrogenase Inhibitors Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Isocitrate Dehydrogenase Inhibitors Market Status and Competition at home and abroad in 2023
-
2.2.2 China Isocitrate Dehydrogenase Inhibitors Market Status and Competition Analysis in 2023
-
2.2.3 China Isocitrate Dehydrogenase Inhibitors Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Isocitrate Dehydrogenase Inhibitors Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Isocitrate Dehydrogenase Inhibitors Industry Development
Chapter 3 Isocitrate Dehydrogenase InhibitorsIndustry Chain Analysis
-
3.1 Isocitrate Dehydrogenase Inhibitors Industry Chain
-
3.2 Isocitrate Dehydrogenase Inhibitors Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Isocitrate Dehydrogenase Inhibitors Market
-
3.3 Isocitrate Dehydrogenase Inhibitors Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Isocitrate Dehydrogenase Inhibitors Market
Chapter 4 China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
4.1 China Isocitrate Dehydrogenase Inhibitors Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Isocitrate Dehydrogenase Inhibitors Total Production Volume and Growth Rate from Production Side
-
4.5 China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate, by Type
-
4.5.1 China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of Others
-
4.5.2 China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of IDH2 Mutant Medullary Malignant Tumor
-
4.5.3 China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of IDH1 Mutant Medullary Malignant Tumor
Chapter 5 China Isocitrate Dehydrogenase Inhibitors Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Isocitrate Dehydrogenase Inhibitors Total Market Size and Growth Rate from Consumption End
-
5.5 China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate, by Application
-
5.5.1 China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of Hedgehog Pathway Inhibitor
-
5.5.2 China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of Others
-
5.5.3 China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of FLT3 Inhibitor
-
5.5.4 China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of DH Inhibitor
Chapter 6 China Isocitrate Dehydrogenase Inhibitors Market, by Region
-
6.1 China Isocitrate Dehydrogenase Inhibitors Production Volume and Production Value, by Region
-
6.2 China Isocitrate Dehydrogenase Inhibitors Sales Volume and Sales Value, by Region
Chapter 7 North China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
7.1 North China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
7.2 North China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 8 Central China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
8.1 Central China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
8.2 Central China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 9 South China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
9.1 South China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
9.2 South China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 10 East China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
10.1 East China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
10.2 East China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 11 Northeast China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
11.1 Northeast China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
11.2 Northeast China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 12 Southwest China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
12.1 Southwest China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
12.2 Southwest China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 13 Northwest China Isocitrate Dehydrogenase Inhibitors Market Analysis
-
13.1 Northwest China Isocitrate Dehydrogenase Inhibitors Market, by Type
-
13.2 Northwest China Isocitrate Dehydrogenase Inhibitors Market, by Application
Chapter 14 Company Profiles
-
14.1 Tragara/Adastra
-
14.1.1 Tragara/Adastra Company Profile
-
14.1.2 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Daiichi Sankyo
-
14.2.1 Daiichi Sankyo Company Profile
-
14.2.2 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Beigene
-
14.3.1 Beigene Company Profile
-
14.3.2 Beigene Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Tesaro
-
14.4.1 Tesaro Company Profile
-
14.4.2 Tesaro Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Celgene
-
14.5.1 Celgene Company Profile
-
14.5.2 Celgene Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bayer
-
14.6.1 Bayer Company Profile
-
14.6.2 Bayer Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Profile
-
14.7.2 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Tocagen
-
14.8.1 Tocagen Company Profile
-
14.8.2 Tocagen Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Aslan Pharmaceuticals
-
14.9.1 Aslan Pharmaceuticals Company Profile
-
14.9.2 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Isocitrate Dehydrogenase Inhibitors Industry Research Conclusions
-
15.2 Isocitrate Dehydrogenase Inhibitors Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Isocitrate Dehydrogenase Inhibitors Industry Market Size (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of IDH2 Mutant Medullary Malignant Tumor (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume, Production Value and Growth Rate of IDH1 Mutant Medullary Malignant Tumor (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of Hedgehog Pathway Inhibitor (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of FLT3 Inhibitor (2018-2029)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Volume, Sales Value and Growth Rate of DH Inhibitor (2018-2029)
-
Figure North China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Central China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure South China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure East China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Isocitrate Dehydrogenase Inhibitors Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Share by Type in 2018
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Share by Type in 2023
-
Figure China Isocitrate Dehydrogenase Inhibitors Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of IDH2 Mutant Medullary Malignant Tumor (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume and Growth Rate of IDH1 Mutant Medullary Malignant Tumor (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Share by Application in 2018
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Share by Application in 2023
-
Figure China Isocitrate Dehydrogenase Inhibitors Total Market Size and Growth Rate from Consumption End
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of Hedgehog Pathway Inhibitor (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of Others (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of FLT3 Inhibitor (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Market Size and Growth Rate of DH Inhibitor (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Production Volume by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Region (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Production Value by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Production Value Share by Region (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Production Value Share by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Sales Volume by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Region (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Sales Value by Region (2018-2023)
-
Table China Isocitrate Dehydrogenase Inhibitors Sales Value Share by Region (2018-2023)
-
Figure China Isocitrate Dehydrogenase Inhibitors Sales Value Share by Region (2018-2023)
-
Table North China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table North China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure North China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table North China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table North China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure North China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Central China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table Central China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Central China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table Central China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table Central China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Central China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table South China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table South China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure South China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table South China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table South China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure South China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table East China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table East China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure East China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table East China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table East China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure East China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Northeast China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table Northeast China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Northeast China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table Northeast China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table Northeast China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Southwest China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table Southwest China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Southwest China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table Southwest China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table Southwest China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Northwest China Isocitrate Dehydrogenase Inhibitors Production Volume by Type (2018-2023)
-
Table Northwest China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Northwest China Isocitrate Dehydrogenase Inhibitors Production Volume Share by Type (2018-2023)
-
Table Northwest China Isocitrate Dehydrogenase Inhibitors Sales Volume by Application (2018-2023)
-
Table Northwest China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Isocitrate Dehydrogenase Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Tragara/Adastra Company Profile
-
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company Profile
-
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Beigene Company Profile
-
Table Beigene Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Tesaro Company Profile
-
Table Tesaro Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Tocagen Company Profile
-
Table Tocagen Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Aslan Pharmaceuticals Company Profile
-
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue, Price and Gross (2018-2023)
-
